Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1633-1635

  Alahgholi Hajibehzad, Mahdi ^a   Yilmaz, Vuslat ^a   Gülsen Parman, Yesim ^a   Aysal, Fikret ^b   Oflazer, Piraye ^a   Deymeer, Feza ^a   Saruhan Direskeneli, Güher ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; MUSCLE SPECIFIC KINASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; ALLELES; FATTY ACIDS, MONOUNSATURATED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; TURKEY; YOUNG ADULT;

EID: 84888201790     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.271     Document Type: Article

References (11)

1. Hoch W M.J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001, 7(3):365.
2. Evoli A., Tonali P.A., Padua L., Monaco M.L., Scuderi F., Batocchi A.P., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003, 126(Pt.10):2304.
3. Saruhan-Direskeneli G., Kilic A., Parman Y., Serdaroglu P., Deymeer F. HLA-DQ polymorphism in turkish patients with myasthenia gravis. Hum Immunol 2006, 67(4-5):352.
4. Giraud M., Beaurain G., Yamamoto M.A., Eymard B., Tranchant C., Gajdos P., et al. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 2001, 57:1555.
5. *15:01 in the Norwegian population. PLoS One 2012, 7(5):e36603.
6. Hjelmstrom P., Giscombe R., Lefvert A.K., et al. Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis. Autoimmunity 1995, 22:59.
7. Niks E.H., Kuks J.B., Roep B.O., Haasnoot G.W., Verduijn W., Ballieux B.E., et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 2006, 66(11):1772.
8. Bartoccioni E., Scuderi F., Augugliaro A., Chiatamone Ranieri S., Sauchelli D., Alboino P., Marino M., Evoli A. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology 2009, 72(2):195.
9. Bunce M., O'Neill C.M., Barnardo M.C.N.M., Krausa P., Browning M.J., Morris P.J., et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46(5):355.
10. Saruhan-Direskeneli G., Esin S., Baykan-Kurt B., Ornek I., Vaughan R., Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997, 55(1):59.
11. Nelis M., Esko T., Magi R., Zimprich F., Zimprich A., Toncheva D., et al. Genetic structure of Europeans: a view from the North-East. PLoS One 2009, 4(5):e5472.